Pharmaceutical

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-based vaccine candidates for monkeypox (Mpox ) prevention.

Sep 19, 2023 - 20:00
BioNTech and CEPI partner to develop Mpox vaccine
BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-based vaccine candidates for monkeypox (Mpox ) prevention.
Read the original article

Tags:

Previous Article

Orexo announces NDA submission to FDA for opioid overdose therapy

Next Article

Pharmanovia announces acquisition of Sanofi’s CNS brands

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AmerisourceBergen is improving access to H2O Therapeutics’s Parky DTx App

AmerisourceBergen is improving access to H2O Therapeuti...

Oct 23, 2023

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit forms to test AI tools used in health care

STAT+: Backed by Mayo Clinic and Microsoft, a nonprofit...

Jan 8, 2024

STAT+: South Africa ordered to disclose contracts with Pfizer, J&J, and other Covid-19 vaccine suppliers

STAT+: South Africa ordered to disclose contracts with ...

Aug 17, 2023